Cancer clinics begin to accommodate patients demanding new cancer detection testsJanuary 9, 2023Preventive CareBreast CancerGastrointestinal CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
New PDT therapy for CTCL to be reviewed by FDADecember 22, 2022Rare DiseasesLymphoma & Plasma Cell Disorders
First recommendations for cancer screening in myositis issuedNovember 12, 2022Rare DiseasesPreventive Care
The broad and challenging – but promising – landscape of peripheral neuropathyOctober 15, 2022Rare DiseasesPatient & Survivor Care
Cancer as a full contact sportOctober 3, 2022Patient & Survivor CarePractice ManagementRenal Cell CarcinomaMetastatic Breast CancerMixed TopicsMelanomaLung Cancer
A farewell to arms? Drug approvals based on single-arm trials can be flawedSeptember 19, 2022Gastrointestinal CancerPractice ManagementMixed TopicsBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic Cancer
Quality of life benefit exaggerated in some cancer studiesJuly 7, 2022Gastrointestinal CancerBreast CancerCNS/Brain CancerGenitourinary CancerGynecologic CancerHead & Neck/Thyroid CancersLeukemia, Myelodysplasia, Transplantation
Myositis guidelines aim to standardize adult and pediatric careMay 13, 2022PediatricsRare DiseasesGastroenterologyPreventive Care
Dodging potholes from cancer care to hospice transitionsMay 6, 2022Patient & Survivor CareBreast CancerCNS/Brain CancerFollicular LymphomaGastrointestinal CancerGenitourinary CancerGynecologic Cancer
Adaptive therapy borrows from nature to keep rhabdomyosarcoma in checkDecember 14, 2021Sarcoma & GISTRare DiseasesPediatrics
Validity of commercial serologic tests for dermatomyositis still questionableNovember 24, 2021Rare Diseases
